Compare ICLR & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICLR | HSIC |
|---|---|---|
| Founded | 1990 | 1932 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.3B |
| IPO Year | 2001 | 1996 |
| Metric | ICLR | HSIC |
|---|---|---|
| Price | $113.35 | $72.55 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 16 |
| Target Price | ★ $178.62 | $85.07 |
| AVG Volume (30 Days) | ★ 1.3M | 998.5K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.21 |
| EPS | N/A | ★ 3.27 |
| Revenue | N/A | ★ $13,201,995,000.00 |
| Revenue This Year | N/A | $6.12 |
| Revenue Next Year | N/A | $3.64 |
| P/E Ratio | ★ $12.91 | $22.14 |
| Revenue Growth | N/A | ★ 5.94 |
| 52 Week Low | $66.57 | $61.97 |
| 52 Week High | $211.00 | $89.29 |
| Indicator | ICLR | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 52.69 | 35.53 |
| Support Level | $99.11 | $70.97 |
| Resistance Level | $116.85 | $74.96 |
| Average True Range (ATR) | 5.40 | 1.94 |
| MACD | 0.33 | -0.62 |
| Stochastic Oscillator | 64.88 | 20.56 |
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.